Browse our collection of papers in
GlaxoSmithKline (GSK)
C/F/176. Risk Management: GlaxoSmithKline
- WORDS:
- 3000
- DATE:
- 2007
- PRICE:
- 39.99 GBP
This report has been aimed at discussing the impact of using effective risk management strategy in an organizational perspective. In order to achieve this aim, researcher has chosen the research and development (R&D) department of one of the top research-based pharmaceutical companies, GlaxoSmithKline (GSK). The analysis has been divided into two distinct parts where the first part identifies the key sources of uncertainty about performance of R&D department, and the management of these uncertainty sources by GSK and their effectiveness.
KEYWORDS: GSK, GlaxoSmithKline, Risk Management, R&D, Pharmaceuticals, Slack,
Other Papers On: GlaxoSmithKline (GSK)
Other Papers On: Risk and Return
Subject Catalogue
- Dissertations and Proposals
- Analysis of Companies
- Analysis of Industries
- Architecture, Design and Technology
- Computing and Mathematics
- E-Commerce and E-Business
- Economics
- Education
- Engineering
- Fashion and Culture
- Finance and Accounting
- General Business
- History
- Hospitality and Tourism
- Human Resource Management
- International Relations
- Law
- Literature, Language and Theatre Studies
- Management and Organisational Behaviour
- Marketing
- Media, Music and Art
- Operations Management
- Philosophy
- Politics
- Psychology
- Science, Medicine and Nursing
- Sociology
Keywords Tag Cloud
glaxosmithkline gsk management dissertation merger financial strategic mergers pharmaceutical change om plc study glaxo beecham performance aquafresh wellcome corporate smithkline operations effects desired acquisition proposal bring astrazeneca market social system value strategy global quality glaxowellcome stock pestel organisational vs managing johnson faced responsibility issues glaxosmithklein healthcare innovation audit intelligence shoeshine safety clinical molecular uk technical environmental disclosures model impact newspaper annual reports flu vaccines directions swine production publicity novartis capability credit operational opportunities investment rating marketing organisations phytopharm reasons swot mix measuring capm security theory disaster using pfizer studies hr shoring india arising challenges communication companies smithline process critical speeding price lean valuation approach backgrounds risk current share comparative benefits implementation development knowledge culture methodology systems soft harbin project role intellectual property innovations negotiation position options british petroleum control construction company portfolio stocks acquisitions critique equilibrium post pre pharmaceuticals final entrepreneurship finance master international investigation overview effect announcement economic benefit glaxosmithklines return c prediction
GET OUR GooGLE TOOLBAR BUTTON
BOOK MARK US
WHAT OTHERS HAVE SAID
The quality of papers on this site is very good and the reference lists are extremely handy.Kevin
